We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Parenteral estrogen versus combined androgen deprivation in the treatment of metastatic prostatic cancer: part 2. Final evaluation of the Scandinavian Prostatic Cancer Group (SPCG) Study No. 5.
- Authors
Hedlund, Per Olov; Damber, Jan-Erik; Hagerman, Inger; Haukaas, Svein; Henriksson, Peter; Iversen, Peter; Johansson, Robert; Klarskov, Peter; Lundbeck, Finn; Rasmussen, Finn; Varenhorst, Eberhard; Viitanen, Jouko; SPCG-5 Study Group
- Abstract
To compare parenteral estrogen therapy in the form of high-dose polyestradiol phosphate (PEP; Estradurin) with combined androgen deprivation (CAD) in the treatment of prostate cancer patients with skeletal metastases. The aim of the study was to compare anticancer efficacy and adverse events, especially cardiovascular events.
- Publication
Scandinavian journal of urology and nephrology, 2008, Vol 42, Issue 3, p220
- ISSN
0036-5599
- Publication type
Journal Article
- DOI
10.1080/00365590801943274